The HSP70 Molecular Chaperone Is Not Beneficial in a Mouse Model of α-synucleinopathy

Derya R. Shimshek, Matthias Mueller, Christoph Wiessner et al. · 2010

Read The HSP70 Molecular Chaperone Is Not Beneficial in a Mouse Model of α-synucleinopathy by Derya R. Shimshek, Matthias Mueller, Christoph Wiessner et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010014.txt.

Description

Derya Shimshek, Matthias Mueller, Christoph Wiessner, and co-workers tested a hoped-for Parkinson's treatment in mice in PLOS ONE in 2010. In Parkinson's disease, a protein called alpha-synuclein folds badly and clumps in the brain. Heat-shock proteins help refold proteins or clear them away, so they looked like a natural way to cut that clump load.

The team raised levels of the chaperone HSP70 in a mouse model of alpha-synuclein disease. Their title gives the plain result: HSP70 was not beneficial there. A clear negative finding like that saves other groups time and steers the search toward other routes.

Catalog record

CREATORDerya R. Shimshek, Matthias Mueller, Christoph Wiessner et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE25 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010014

Browse the full library · About the Tower of Babel